Multicenter Experience with Maxillary Prostheses Supported by Brånemark Implants: A Clinical Report
Koichiro Ihara, DDS, Masaaki Goto, DDS, PhD, Akira Miyahara, DDS, Junichiro Toyota, DDS, Takeshi Katsuki, DDS, PhD.
PMID: 9714960
This retrospective study involved Japanese patients with prostheses supported by Brånemark implants following maxillectomy. Questionnaires were sent to 75 institutions, and data on 19 patients were collected from 8 institutions. The mean age of patients at the time of implant placement was 64.2 years (range 22 to 82 years). The mean follow-up time was 27.6 months. Of the 81 implants placed, 16 were lost for an implant survival rate of 80.2%. The effects on implant survival rate of radiotherapy, chemotherapy, hyperbaric oxygen therapy, and the support system of the prosthesis were analyzed, but no significant differences were observed. (INT J ORAL MAXILLOFAC IMPLANTS 1998;13:531–538) Key words: Brånemark implants, chemotherapy, maxillary prostheses, maxillary tumor, multicenter study, radiotherapy, survival rate
| © 2013 Quintessence Publishing Co, Inc |
JOMI Home Current Issue Ahead of Print Archive Author Guidelines About |
Accepted Manuscripts Submission Form Submit Reprints Permission Advertising |
Quintessence Home Terms of Use Privacy Policy About Us Contact Us Help |